VSN Verseon (DI)

TIDMVSN

RNS Number : 3373D

Verseon Corporation

26 April 2017

 
 Press release   April 26, 2017 
 

Verseon Corporation

("Verseon" or the "Company")

Result of 2017 Annual General Meeting

FREMONT, Calif.-Verseon Corporation (AIM:VSN), a technology-based pharmaceutical company, confirms that all resolutions put to shareholders at the Company's Annual General Meeting held on April 25, 2017 at 14:00 PDT (22:00 BST) were duly passed.

- Ends -

For further information, please contact

 
 Verseon Corporation                www.verseon.com 
                                       +1 (510) 225 
 Tina Schlafly                                 9000 
 
 Cenkos Securities (NOMAD and 
  Joint Broker) 
                                         +44 (0) 20 
 Neil McDonald / Beth McKiernan           7397 8900 
 
 Cantor Fitzgerald Europe (Joint 
  Broker) 
 Marc Milmo / Phil Davies /              +44 (0) 20 
  Callum Butterfield                      7894 7000 
 
 Mirabaud Securities LLP (Joint 
  Broker) 
                                         +44 (0) 20 
 Peter Krens                              7321 2508 
 

For financial and business media enquiries, please contact

 
 Buchanan Communications Ltd 
  (PR Advisers) 
 Henry Harrison-Topham / Jamie    +44 (0) 20 
  Hooper                           7466 5000 
 

For trade and pharma media enquiries, please contact

 
 Vane Percy & Roberts 
                         +44 (0) 1737 
 Simon Vane Percy             821 890 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGGSGDSLUDBGRL

(END) Dow Jones Newswires

April 26, 2017 02:01 ET (06:01 GMT)

Verseon (LSE:VSN)
Historical Stock Chart
From Mar 2024 to Apr 2024

Verseon (LSE:VSN)
Historical Stock Chart
From Apr 2023 to Apr 2024